Answers are grounded in this paper and cite their sources.
Silencing of the BRCA1 gene by promoter hypermethylation occurs in primary breast and ovarian carcinomas, especially in the presence of LOH and in specific histopathologic subgroups. These findings support a role for this tumor suppressor gene in sporadic breast and ovarian tumorigenesis.
No takes yet. Share an insight, caveat, or question.
Manel Esteller (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: